转移性激素敏感性前列腺癌患者是否可以进行降级治疗？
Is There a Place for De-escalating Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer?
发表日期：2024 Jul 01
作者：
Fabio Turco, Bertrand Tombal, Silke Gillessen, Aurelius Omlin
来源：
European Urology Focus
摘要：
尽管过去经常推荐间歇性雄激素剥夺疗法用于转移性激素敏感癌症治疗，但我们不知道其使用是否可以推广到联合治疗。评估间歇性治疗的试验是必要的，因为这种策略可以改善患者的生活质量并减少不良事件和费用。版权所有 © 2024 欧洲泌尿外科协会。由 Elsevier B.V. 出版。保留所有权利。
Although intermittent androgen deprivation therapy was often recommended for metastatic hormone-sensitive cancer therapy in the past, we do not know whether its use can be extrapolated to combination therapy. Trials evaluating intermittent therapy are necessary as this strategy could improve patient quality of life and reduce adverse events and costs.Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.